Minerva Neurosciences Reports First Quarter 2017 Financial Results And Business Updates Post author:Sam Post published:May 3, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Johnson & Johnson Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner April 18, 2017 IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017 <b>ADC Bio</b> To Invest $11 Million On Bioconjugation Facility September 26, 2017
Johnson & Johnson Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner April 18, 2017
IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017